NASDAQ

Xilio Therapeutics, Inc. (XLO)

♥ 652 Thanks from members

Live price chart, market sentiment, and community perspectives for Xilio Therapeutics, Inc. (NASDAQ: XLO).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Xilio Therapeutics ScientistsLeadership: Rene Russo (President and CEO)Holder: Atlas VentureHolder: Fidelity Management and ResearchHolder: Sanofi VenturesXT002XT301Tumor-Activated Therapeutics#XLO#Xilio Therapeutics#Immuno-Oncology#Biotech#NASDAQ XLO